FDA withdraws GSK’s approval of drug touted as autism treatment

US regulators have withdrawn their approval of a GSK Plc drug that the Trump administration had promoted as a treatment for ...
RAPS

FDA Warns GSK’s UK Site for Contamination in API Manufacturing

The US Food and Drug Administration (FDA) on Wednesday released a warning letter for GlaxoSmithKline’s Worthing, UK-based active pharmaceutical ingredient (API) manufacturing site. The warning letter, ...